Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mydriatic microdrops for ROP screening
NCT05043077Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Sep 2021
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of phenylephrine, tropicamide in retinopathy of prematurity (ROP), sponsored by Aristotle University of Thessaloniki. Started Sep 2021; status: completed.
02
Drugs
phenylephrinetropicamide
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT05043077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05043077.